# FDA Inspection 1220251 - Gland Pharma Limited - July 28, 2023

Source: https://www.globalkeysolutions.net/records/fda_inspections/gland-pharma-limited/f25e54d0-1f98-45a4-8226-c8aa54a8bf11/
Source feed: FDA_Inspections

> FDA Inspection 1220251 for Gland Pharma Limited on July 28, 2023. Classification: No Action Indicated (NAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1220251
- Company Name: Gland Pharma Limited
- Inspection Date: 2023-07-28
- Classification: No Action Indicated (NAI)
- Project Area: Drug Quality Assurance
- Product Type: Drugs
- Office Name: Center for Drug Evaluation and Research

## Related Documents

- [FDA Inspection 1110628 - 2019-11-01](https://www.globalkeysolutions.net/api/records/fda_inspections/gland-pharma-limited/dcb210ce-c362-4c32-9e94-f2665152f61b/)
- [FDA Inspection 1061075 - 2018-06-15](https://www.globalkeysolutions.net/api/records/fda_inspections/gland-pharma-limited/ba25fee5-0b52-447f-8306-e2894b341fe9/)
- [FDA Inspection 1056489 - 2018-05-18](https://www.globalkeysolutions.net/api/records/fda_inspections/gland-pharma-limited/c53d2600-72cd-4e81-a9e1-34e69012a144/)
- [FDA Inspection 1010051 - 2017-03-31](https://www.globalkeysolutions.net/api/records/fda_inspections/gland-pharma-limited/f11bc613-6f2c-4144-ad0f-51acc97a860d/)
- [FDA Inspection 936901 - 2015-06-30](https://www.globalkeysolutions.net/api/records/fda_inspections/gland-pharma-limited/fac87dc6-d40d-4506-80ef-5a93a790d2ce/)

Company: https://www.globalkeysolutions.net/companies/gland-pharma-limited/9d02bb1e-32f9-45c5-9b90-f52622553c63

Office: https://www.globalkeysolutions.net/offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c